Is target population more important than patient location when evaluating tight glycemic control?

被引:1
|
作者
Gibson, B. Robert [1 ]
Sevransky, Jonathan E. [2 ]
机构
[1] Johns Hopkins Med Inst, Dept Surg, Baltimore, MD 21205 USA
[2] Johns Hopkins Med Inst, Div Pulm & Crit Care Med, Baltimore, MD 21205 USA
关键词
tight glucose control; fibrinolysis; sepsis; insulin therapy; plasminogen activator inhibitor-1; INTENSIVE INSULIN THERAPY; RESUSCITATION; FIBRINOLYSIS; COAGULATION;
D O I
10.1097/CCM.0b013e318195468e
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
引用
收藏
页码:741 / 742
页数:2
相关论文
共 50 条